These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10182698)

  • 1. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.
    Fed Regist; 1998 Aug; 63(168):46171-4. PubMed ID: 10182698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.
    Fed Regist; 1998 Jun; 63(104):29552-90. PubMed ID: 10179863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.
    Fed Regist; 1998 Sep; 63(183):50660-704. PubMed ID: 10185803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural rubber-containing medical devices; user labeling--FDA. Final rule.
    Fed Regist; 1997 Sep; 62(189):51021-30. PubMed ID: 10175218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural rubber-containing medical devices; user labeling; cold seal adhesives partial stay--FDA. Final rule.
    Fed Regist; 1998 Aug; 63(168):46174-5. PubMed ID: 10182699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural rubber-containing medical devices; user labelling--FDA. Final rule; interpretation.
    Fed Regist; 1998 May; 63(87):24934-5. PubMed ID: 10179326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; medical device distributor reporting--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.
    Fed Regist; 1993 Sep; 58(168):46514-23. PubMed ID: 10128335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical devices; device tracking--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.
    Fed Regist; 1992 May; 57(104):22966-70. PubMed ID: 10171013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstetrical and gynecological devices; designation of special controls for male condoms made of natural rubber latex.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Nov; 73(218):66522-39. PubMed ID: 19112703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical devices; humanitarian use of devices--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Jul; 63(147):40825. PubMed ID: 10181716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical devices; medical device distributor reporting; opportunity for comments--FDA. Final rule; opportunity for comments.
    Fed Regist; 1993 Sep; 58(168):46514. PubMed ID: 10128334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical devices; reports of corrections and removals; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Aug; 63(152):42300-4. PubMed ID: 10181727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(224):64556-88. PubMed ID: 10339052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Aug; 63(154):42699. PubMed ID: 10182563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical devices; labeling for menstrual tampon for the "ultra" absorbency. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Oct; 65(202):62282-5. PubMed ID: 11503680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Sep; 63(188):51874-5. PubMed ID: 10185813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-free number for reporting adverse events on labeling for human drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Oct; 73(209):63886-97. PubMed ID: 19112682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General and plastic surgery devices; classification of silicone sheeting. Final rule.
    Food and Drug Administration. HHS
    Fed Regist; 2004 Aug; 69(152):48146-8. PubMed ID: 15300956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical devices; labeling for menstrual tampons; ranges of absorbency, change from "junior" to "light." Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Aug; 69(164):52170-1. PubMed ID: 15329983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dental devices; dental noble metal alloys and dental base metal alloys; designation of special controls. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Aug; 69(162):51765-6. PubMed ID: 15329980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.